Table 1.
Relationship between the expression of Cyclin D1 and clinical indicators of breast cancer (%)
| Clinical indicators | N | Cyclin D1 | χ2 | P | ||
|---|---|---|---|---|---|---|
|
| ||||||
| Negative | Weak positive | Strong positive | ||||
| Age | ||||||
| ≥ 60 | 46 | 14 (30.4) | 20 (43.5) | 12 (26.1) | 5.329 | 0.255 |
| ≥ 40-59 | 117 | 21 (17.9) | 51 (43.6) | 45 (38.5) | ||
| ≤ 39 | 63 | 52 (23.0) | 100 (44.2) | 74 (32.7) | ||
| Tumor diameter | ||||||
| ≤ 1 | 141 | 27 (19.1) | 61 (43.3) | 53 (37.6) | 16.526 | 0.002 |
| ≤ 2 | 23 | 8 (34.8) | 4 (17.4) | 11 (47.8) | ||
| ≤ 3 | 62 | 17 (27.4) | 35 (56.5) | 10 (16.1) | ||
| Total lymphoid | ||||||
| L (-) | 169 | 44 (26.0) | 78 (46.2) | 47 (27.8) | 13.543 | 0.009 |
| L (0-4) | 37 | 5 (13.5) | 18 (48.6) | 14 (37.8) | ||
| L > 4 | 20 | 3 (15.0) | 4 (20.0) | 13 (65.0) | ||
| Chemotherapy | ||||||
| Yes | 199 | 49 (24.6) | 92 (46.2) | 58 (29.1) | 9.952 | 0.007 |
| No | 27 | 3 (11.1) | 8 (29.6) | 16 (59.3) | ||
| Radiotherapy | ||||||
| Yes | 159 | 29 (18.2) | 76 (47.8) | 54 (34.0) | 7.075 | 0.029 |
| No | 67 | 23 (34.3) | 24 (35.8) | 20 (29.9) | ||